Ariadne Wealth Management »

Alnylam Pharmaceuticals shares owned by Ariadne Wealth Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Ariadne Wealth Management from 13F filings

Historical chart of Ariadne Wealth Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Ariadne Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Ariadne Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $233k 855 272.22

More positions owned by Ariadne Wealth Management

Ishares Tr Russell 3000 Etf (IWV)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
American Centy Etf Tr Us Eqt Etf (AVUS)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Ishares Silver Tr Ishares (SLV)
Dimensional Etf Trust Us Equity Etf (DFUS)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Internatnal Val (DFIV)
Microsoft Corporation (MSFT)
Ishares Tr Blackrock Ultra (ICSH)
Spdr Gold Tr Gold Shs (GLD)
American Centy Etf Tr Avantis Intl Sml (AVDS)

View all positions for Ariadne Wealth Management

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment
Winslow Capital Management
Susquehanna International
Bellevue Group

View all funds holding Alnylam Pharmaceuticals